CADILAHC Intraday Analysis...

CADILAHC Share Price

Open 505.00 Change Price %
High 511.00 1 Day -15.35 -3.04
Low 487.10 1 Week 7.15 1.48
Close 489.10 1 Month 20.60 4.40
Volume 1496657 1 Year 97.05 24.75
52 Week High 560.00
52 Week Low 328.80
CADILAHC Important Levels
Resistance 2 511.26
Resistance 1 502.13
Pivot 495.73
Support 1 476.07
Support 2 466.94
NSE INDIA Most Active Stocks
JPASSOCIAT 18.15 -5.96%
RCOM 19.85 -5.25%
SUZLON 16.30 -4.12%
SOUTHBANK 29.30 -5.64%
GMRINFRA 16.75 -4.29%
UNITECH 6.95 -5.44%
JPPOWER 7.50 2.04%
ITI 139.45 13.93%
ITI 139.45 13.93%
ICICIBANK 277.10 -2.75%
More..
NSE INDIA Top Gainers Stocks
SPYL 0.40 14.29%
ITI 139.45 13.93%
ITI 139.45 13.93%
XLENERGY 1.80 12.50%
PRAKASHCON 4.60 10.84%
ORCHIDPHAR 23.60 10.54%
LYCOS 6.30 9.57%
GENESYS 298.55 7.18%
TARMAT 47.00 6.46%
JMA 223.80 6.12%
More..
NSE INDIA Top Losers Stocks
RHFL 107.20 -86.91%
ADHUNIKIND 79.10 -19.98%
A2ZINFRA 37.45 -12.50%
PALREDTEC 99.70 -12.08%
PANORAMUNI 8.50 -11.46%
GABRIEL 188.10 -11.46%
SABTN 104.20 -9.98%
TVVISION 139.90 -9.97%
PENINLAND 24.95 -9.93%
KSK 10.00 -9.91%
More..

Cadila Healthcare Limited (NSE: CADILAHC)

CADILAHC Technical Analysis 1.5
As on 22nd Sep 2017 CADILAHC Share Price closed @ 489.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 444.15 & Sell for SHORT-TERM with Stoploss of 507.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
CADILAHC Target for September
1st Target up-side 564.26
2nd Target up-side 609.29
3rd Target up-side 654.33
1st Target down-side 435.74
2nd Target down-side 390.71
3rd Target down-side 345.67
CADILAHC Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 47.59 Sideways
MFI (14) MFI is 47.33 Sideways
CCI (20) CCI is 3.56 Sideways
WILLIAM %R (14) William %R is -59.10 Sideways
ADX (14) ADX is 19.85 Range Bound
PSAR Stoploss For Long Buy 468.89
10 Day Avg Volume Traded 10.30 % More then 10 Day Average Volume
CADILAHC Other Details
Segment EQ
Market Capital 40527183872.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.zyduscadila.com
CADILAHC Address
CADILAHC
Zydus Tower
Satellite Cross Roads
Ahmedabad, 380015
India
Phone: 91 79 2686 8100
Fax: 91 79 2686 2365
Interactive Technical Analysis Chart Cadila Healthcare Limited ( CADILAHC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cadila Healthcare Limited
CADILAHC Business Profile
Cadila Health is in the Pharmaceuticals sector. Cadila Laboratories was founded in 1952 by Ramanbhai Patel(1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Shri Indravadan Modi. The company evolved over the next four decades into one of India's established pharmaceutical companies. In 1995 the Patel and Modi families split, with the Modi family's share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel family's holding company. Cadila Healthcare did its IPO on the Bombay Stock Exchange in 2000. Its stock code on the Bombay exchange is 532321. In 2001 the company acquired another Indian pharmaceutical company called German Remedies. On June 25, 2007, the company signed an agreement to acquire 100 per cent stake in Brazil's Quimica e Farmaceutica Nikkho do Brasil Ltda (Nikkho) for around 26 million dollars. In 2010, Cadila Pharmaceuticals received a prestigious Wellcome Trust Award under the new "R&D for Affordable Healthcare in India" initiative. The current market capitalisation stands at Rs 15,310.07 crore.The company has reported a consolidated sales of Rs 1746.79 crore and a Net Profit of Rs 191.57 crore for the quarter ended Sep 2013. The company management includes Pankaj R Patel - Chairman & Managing Director, Sharvil P Patel - Deputy Managing Director, Humayun Dhanrajgir - Director, Mukesh M Patel - Director, Nitin R Desai - Director, Apurva S Diwanji - Director. It is listed on the BSE with a BSE Code of 532321 and the NSE with an NSE Code of CADILAHC. Its Registered office is at "Zydus Tower", Satellite Cross Roads,,Sarkhej Gandhinagar Highway Ahmedabad,Gujarat - 380015.